Items where authors include "Cameron, DA"

Export as [feed] Atom [feed] RSS
Number of items: 8.

Article

Bundred, N, Porta, N, Brunt, AM et al. (20 more authors) (2022) Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results. Clinical Cancer Research. ISSN 1078-0432

Hall, PS, Smith, A orcid.org/0000-0001-7709-1869, Hulme, C orcid.org/0000-0003-2077-0419 et al. (15 more authors) (2017) Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial. Value in Health, 20 (10). pp. 1311-1318. ISSN 1098-3015

Thomas, JS, Hanby, AM orcid.org/0000-0001-7966-1570, Russell, N et al. (10 more authors) (2017) The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer. Breast Cancer Research and Treatment, 163 (1). pp. 63-69. ISSN 0167-6806

Gregory, WM, Twelves, CJ, Bell, R et al. (4 more authors) (2016) Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling. Breast Cancer Research and Treatment, 155 (2). pp. 303-311. ISSN 0167-6806

Hall, P, Smith, AFC, Vargas-Palacios, A et al. (20 more authors) (2015) UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer. Cancer Research, 75 (9). Abstract P6-08-11. ISSN 0008-5472

Cameron, DA, Anderson, A, Toy, E et al. (9 more authors) (2002) Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer? British Journal of Cancer, 87 (12). pp. 1365-1369. ISSN 0007-0920

Conference or Workshop Item

Stein, RC, Makris, A, MacPherson, IR et al. (17 more authors) (2021) Optima: Optimal personalised treatment of early breast cancer using multi-parameter analysis, an international randomized trial of tumor gene expression test-directed chemotherapy treatment in a largely node-positive population. In: 2021 ASCO Annual Meeting, 04-08 Jun 2021, Virtual.

Stavraka, C, Evans, TRJ, Dunlop, J et al. (6 more authors) (2020) Abstract P2-16-15: 10-year outcome for women randomized in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: An anglo-celtic cooperative oncology group study. In: Abstracts: 2019 San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas, 10-14 Dec 2019, San Antonio, Texas, USA.

This list was generated on Sat Mar 23 09:48:24 2024 GMT.